会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • A METHOD FOR NONINVASIVELY AND QUANTITATIVELY MONITORING THERAPEUTIC AND DIAGNOSTIC TRANSGENE EXPRESSION INDUCED BY EX VIVO AND IN VIVO GENE TARGETING IN ORGANS, TISSUES AND CELLS
    • 一种无创和定量监测EXVIVO和VIVO基因指导在器官,组织和细胞中诱导的诊断和诊断转移表达的方法
    • WO2007109335A3
    • 2008-10-09
    • PCT/US2007007048
    • 2007-03-20
    • UNIV CALIFORNIASEN LUYIGAMBHIR SANJIV S
    • SEN LUYIGAMBHIR SANJIV S
    • C12Q1/68A61K49/00G21H5/02
    • C12Q1/6897
    • An composition in a method for noninvasively monitoring the expression of therapeutic transgene delivered ex vivo and in vivo for the treatment of diseases includes the step of quantitatively imaging a reporter gene expression which is coupled to a therapeutic gene on a plasmid vector to infer levels, location, or duration of the therapeutic gene expression in the targeted tissues or organs. The reporter gene is imaged using a radiopharmaceutical for scintigraphic imaging of the gene expression interactions with the reporter gene, namely positron emission tomography, gamma camera or single-photon emission computed tomography. The genes are delivered with a liposome encapsulated reporter-therapeutic linked transgene vector with balanced reporter/therapeutic transgene expression. A transgene composition includes the reporter gene linked to the therapeutic gene or genes incorporated in and delivered by a liposome encapsulated reporter-therapeutic linked transgene vector.
    • 用于非侵入性监测离体和体内递送的用于治疗疾病的治疗性转基因表达的方法中的组合物包括定量成像与质粒载体上的治疗基因偶联的报告基因表达以推断水平,位置 或靶向组织或器官中治疗性基因表达的持续时间。 使用放射性药物对报告基因进行成像,用于与报告基因的基因表达相互作用的闪烁照相成像,即正电子发射断层扫描,γ照相机或单光子发射计算机断层摄影。 基因与具有平衡的报告基因/治疗性转基因表达的脂质体封装的报告基因治疗连接的转基因载体递送。 转基因组合物包括与治疗基因连接的报告基因或掺入脂质体封装的报告基因 - 治疗连锁的转基因载体并递送的基因。
    • 5. 发明申请
    • AN APPARATUS AND METHOD FOR IN VIVO INTRACELLULAR TRANSFECTION OF GENE, SIRNA, SHRNA VECTORS, AND OTHER BIOMEDICAL DIAGNOSTIC AND THERAPEUTIC DRUGS AND MOLECULES FOR THE TREATMENT OF ARTHRITIS AND OTHER ORTHOPEDIC DISEASEAS IN LARGE ANIMALS AND HUMAN
    • 用于基因,SIRNA,SHRNA载体和其他生物医学诊断和治疗药物的体内细胞转染的装置和方法以及用于治疗大动物和人类中的ARTHRITIS和其他正常疾病的分子
    • WO2008086064A2
    • 2008-07-17
    • PCT/US2008050059
    • 2008-01-02
    • UNIV CALIFORNIASEN LUYI
    • SEN LUYI
    • A61N1/30
    • A61N1/327A61N1/325
    • An apparatus for in vivo intracellular transfection of gene, siRNA, shRNA vectors, and other biomedical diagnostic and therapeutic drugs and molecules for the treatment of arthritis and other orthopedic diseases in large animals and humans includes: a source of low voltage, short duration pulses in long duration bursts (LSEN); an electrode mesh system coupled to the source for generating distributed electric field network into a joint, including bones, cartilages, and related tissues; and means for transfecting the gene, siRNA, shRNA vectors, and other biomedical diagnostic and therapeutic drugs and molecules into a joint. The electrode mesh system includes alternatively arranged negative and positive electrodes in a first array which is capable of being inserted into a joint cavity, and either an alternatively arranged negative and positive or an all negative second electrode array which is positioned outside of the joint and in directly contact with overlying skin.
    • 用于体内细胞内转染基因,siRNA,shRNA载体和其他用于治疗大动物和人类中的关节炎和其他整形外科疾病的生物医学诊断和治疗药物和分子的装置包括:低电压,短持续脉冲源 长时间突发(LSEN); 耦合到所述源的电极网系统,用于将分布式电场网络发生到包括骨骼,软骨和相关组织在内的关节中; 以及将基因,siRNA,shRNA载体和其他生物医学诊断和治疗药物和分子转染到关节中的方法。 电极网系统包括可排列的第一阵列中的负电极和正电极,该第一阵列能够插入到接合腔中,以及位于接头外侧的交替布置的负极和正极或全负极第二电极阵列 直接接触上皮肤。
    • 6. 发明申请
    • AN APPARATUS AND METHOD FOR OPTIMIZATION OF CARDIAC RESYNCHRONIZATION THERAPY
    • 用于优化心脏再生治疗的装置和方法
    • WO2008024857A2
    • 2008-02-28
    • PCT/US2007076543
    • 2007-08-22
    • UNIV CALIFORNIACUI GUANGGENSEN LUYI
    • CUI GUANGGENSEN LUYI
    • A61N1/00
    • A61N1/056A61B5/0422A61N1/3627
    • An apparatus and method for biventricular pacing comprises means and steps for i) evidence-based, ii) optimized, iii) simultaneously evidence-based and optimized endomyocardium and iv) optimized epimyocardium pacing in cardiac resynchronization. Monophasic action potential is mapped by evidence-based and individualized optimization of cardiac resynchronization, pacing and implantable cardioverter defibrillators in percutaneous procedures, thoracoscopic procedures or open chest surgeries. The optimized electrode sites are identified without MAP mapping without use of an electrophysiologic system for optimized cardiac resynchronization, pacing and an implantable cardioverter defibrillator in percutaneous procedures, thoracoscopic procedures or open chest surgeries. The effectiveness of this therapy is optimized in a majority of patients with heart failure, left ventricular (LV) or right ventricular (RV) dysfunction, cardiomyopathies, arrhythmias, congenital heart diseases, heart transplantations, and/or in patients immediately after open heart surgeries for fast recovery.
    • 用于双心室起搏的装置和方法包括以下步骤:i)基于证据,ii)优化,iii)同时基于证据和优化的心内膜,以及iv)心脏再同步中优化的心外膜起搏。 通过基于证据和个体化优化的心脏再同步,起搏和植入式心律转复除颤器在经皮手术,胸腔镜手术或胸部手术中的单相动作电位。 在经皮程序,胸腔镜手术或开放性胸部手术中,不使用电生理系统来优化电极位点,无需使用电生理系统优化心脏再同步,起搏和植入式心律转复除颤器。 在大多数心力衰竭,左心室(LV)或右心室(RV)功能障碍,心肌病,心律失常,先天性心脏病,心脏移植和/或在开心手术后立即进行的患者中,该疗法的有效性被优化 为快速恢复。